← back to search

Patrizio Caturegli

Johns Hopkins Hospital · US
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Thyroid Disorders and Treatments, Pituitary Gland Disorders and Treatments, Adrenal Hormones and Disorders, and Growth Hormone and Insulin-like Growth Factors.
h-index
52
citations
11,521
works
606
NIH funding
primary concept
Medicine
email

Recent publications

Leveraging a naturally occurring IgM autoantibody to target diabetogenic T cells: a precision medicine approach to type 1 diabetes.
2026cited by 0position: contributordoi
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
JCI Insight 2024cited by 12position: middledoi
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
JCI Insight 2024cited by 11position: contributordoi
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas.
2024cited by 2position: contributordoi
Falsely abnormal serum protein electrophoresis after administration of intravenous immunoglobulins (IVIG): A retrospective cohort study.
2024cited by 1position: contributordoi
A Potential Screening Strategy to Identify Probable Syphilis Infections in the Urban Emergency Department Setting.
2024cited by 0position: contributordoi
MyMD-1 Improves Health Span and Prolongs Life Span in Old Mice: A Noninferiority Study to Rapamycin.
2023cited by 10position: contributordoi
Liver kidney microsome antibodies. Analysis of a laboratory series.
2023cited by 0position: contributordoi
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Blood Advances 2022cited by 58position: middledoi
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses
Immunity 2022cited by 39position: middledoi
Pre-existing Thyroid Autoimmunity and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study of US Active-Duty Personnel.
2022cited by 24position: contributordoi
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel
JAMA Network Open 2021cited by 155position: middledoi
Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection
JAMA 2021cited by 117position: middledoi
Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model.
2021cited by 14position: contributordoi
Th17 Cells Contribute to the Pathology of Autoimmune Hypophysitis.
2021cited by 13position: contributordoi
Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model.
2021cited by 11position: contributordoi
A Comparison of gel (Hydragel 30) and capillary (Capillarys III Tera) electrophoresis for the characterization of human serum proteins.
2021cited by 0position: contributordoi
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Science 2020cited by 768position: middledoi
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Journal of Clinical Microbiology 2020cited by 260position: middledoi
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
The Journal of Infectious Diseases 2020cited by 118position: middledoi
Clinical Validity of Serum Antibodies to SARS-CoV-2 : A Case-Control Study.
2020cited by 46position: contributordoi
Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment
Expert Review of Endocrinology & Metabolism 2019cited by 125position: lastdoi
Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment.
2019cited by 92position: contributordoi
MYMD-1, a Novel Immunometabolic Regulator, Ameliorates Autoimmune Thyroiditis via Suppression of Th1 Responses and TNF-α Release.
2019cited by 16position: contributordoi
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
Thyroid 2017cited by 332position: middledoi
In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis
Scientific Reports 2017cited by 35position: middledoi
Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
American Journal Of Pathology 2016cited by 374position: firstdoi
New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
Journal of Immunology Research 2015cited by 163position: middledoi
Hashimoto thyroiditis: Clinical and diagnostic criteria
Autoimmunity Reviews 2014cited by 1,030position: firstdoi
Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
Science Translational Medicine 2014cited by 697position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 14 papers (2019–2026)Oliver Laeyendecker · Anna Needs Neuroblastoma Answers4 papers (2020–2024)Alessandra De Remigis · Novo Nordisk (Denmark)3 papers (2012–2014)Giulia Di Dalmazi · Johns Hopkins Medicine3 papers (2019–2021) · 2 papers (2016–2019)Shintaro Iwama · Nagoya University2 papers (2012–2014)Aaron M. Milstone · Johns Hopkins Medicine2 papers (2021–2021)H. Benjamin Larman · University of Baltimore2 papers (2016–2020)Andrew Pekosz · Johns Hopkins University2 papers (2020–2020)Giulia Di Dalmazi · University of Chieti-Pescara2 papers (2016–2019)Silvia Ippolito · Springer Nature2 papers (2021–2022) · 2 papers (2024–2024)William Clarke · University of Queensland2 papers (2020–2020)David L. Thomas · Johns Hopkins University1 papers (2020–2020)Clare Rock · Johns Hopkins Medicine1 papers (2021–2021)Julia M. Baker · Centers for Disease Control and Prevention1 papers (2021–2021)Michael J. Betenbaugh · Johns Hopkins University1 papers (2020–2020)Akiko Iwama · Johns Hopkins Medicine1 papers (2012–2012)Srilatha Edupuganti · Emory University1 papers (2020–2020)Owen R. Baker · National Institute of Allergy and Infectious Diseases1 papers (2020–2020)